XML 19 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Balance Sheet - USD ($)
$ in Millions
Mar. 31, 2025
Dec. 31, 2024
Assets    
Cash and cash equivalents $ 1,489 $ 1,738
Inventories 5,240 3,995
Prepaid expenses and other current assets 1,329 1,144
Total Current Assets 18,279 17,910
Investments and long-term receivables 13,359 14,378
Net properties, plants and equipment 34,966 35,264
Goodwill 1,575 1,575
Intangibles 1,167 1,161
Other assets 2,492 2,294
Total Assets 71,838 72,582
Liabilities    
Short-term debt 1,061 1,831
Accrued income and other taxes 1,247 1,060
Employee benefit obligations 372 732
Other accruals 1,478 1,160
Total Current Liabilities 14,883 15,087
Long-term debt 17,742 18,231
Asset retirement obligations and accrued environmental costs 1,151 1,129
Deferred income taxes 6,972 7,101
Employee benefit obligations 690 703
Other liabilities and deferred credits 2,047 1,868
Total Liabilities 43,485 44,119
Equity    
Common stock (2,500,000,000 shares authorized at $0.01 par value) Issued (2025—658,173,402 shares; 2024—656,987,861 shares) par value 7 7
Capital in excess of par 19,789 19,788
Treasury stock (at cost: 2025—250,591,516 shares; 2024—248,594,923 shares) (22,995) (22,751)
Retained earnings 30,785 30,771
Accumulated other comprehensive loss (313) (407)
Total Stockholders’ Equity 27,273 27,408
Noncontrolling interests 1,080 1,055
Total Equity 28,353 28,463
Total Liabilities and Equity 71,838 72,582
Nonrelated Party    
Assets    
Accounts and notes receivable (net of allowances of $70 million in 2025 and 2024) 8,616 9,544
Liabilities    
Accounts payable 10,034 9,792
Related Party    
Assets    
Accounts and notes receivable (net of allowances of $70 million in 2025 and 2024) 1,605 1,489
Liabilities    
Accounts payable $ 691 $ 512